Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 20/20 | 0.80 |
| ▸ | ADORA2A | P29274 | 19/20 | 0.80 |
| ▸ | ADORA1 | P30542 | 19/20 | 0.80 |
| ▸ | ADORA3 | P0DMS8 | 9/20 | 0.80 |
| ▸ | PLK4 | O00444 | 1/20 | 0.77 |
| ▸ | CDK2 | P24941 | 1/20 | 0.77 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.77 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.77 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.77 |
| ▸ | CSNK1G3 | Q9Y6M4 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1946601 | 0.87 | ADORA2A (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| Gs 6201 SCHEMBL29504137 | 0.87 | ADORA2B (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| Gs 6201 SCHEMBL238694 | 0.87 | ADORA2B (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| Gs 6201 SCHEMBL29504135 | 0.87 | ADORA2B (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| Gs 6201 SCHEMBL29504138 | 0.87 | ADORA2B (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| Gs 6201 SCHEMBL29504136 | 0.87 | ADORA2B (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL242026 | 0.86 | ADORA2B (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL1944369 | 0.85 | ADORA2B (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL1944547 | 0.85 | ADORA2B (0.78) | ADORA2BADORA2AADORA1ADORA3PLK4 | |
| SCHEMBL1945880 | 0.85 | ADORA2B (1.00) | ADORA2BADORA2AADORA1ADORA3PLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1685132-A1 | A sb 2B /sb ADENOSINE RECEPTOR ANTAGONISTS | CV THERAPEUTICS, INC. (US) | 2006-08-02 | — | — | EP | disclosed |
| WO-2005051951-A1 | A2B ADENOSINE RECEPTOR ANTAGONISTS | CV THERAPEUTICS, INC. (US) | 2005-06-09 | — | — | WO | disclosed |